| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A2 SLIT2 FBN1 VWF LAMA2 CRELD2 TECTA SSPOP AGRN TNXB FBN3 | 2.63e-10 | 188 | 81 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.09e-09 | 16 | 81 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | SLIT2 FBN1 MEGF6 DLL4 ENPP3 LRP1 LRP4 CRELD2 DSG4 DLK1 PLCH1 LRP1B AGRN FBN3 NOTCH3 NOTCH4 LRP8 | 6.53e-09 | 749 | 81 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.87e-08 | 21 | 81 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.25e-06 | 85 | 81 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 6.97e-05 | 20 | 81 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | histone H4K20 demethylase activity | 9.70e-05 | 4 | 81 | 2 | GO:0035575 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.38e-04 | 194 | 81 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 1.41e-04 | 65 | 81 | 4 | GO:0016706 | |
| GeneOntologyMolecularFunction | histone H4 demethylase activity | 1.61e-04 | 5 | 81 | 2 | GO:0141058 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.96e-04 | 28 | 81 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.18e-04 | 29 | 81 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A2 SLIT2 FBN1 VWF LAMA2 CRELD2 EVPL TECTA SSPOP AGRN TNXB FBN3 | 2.40e-04 | 891 | 81 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | histone demethylase activity | 2.66e-04 | 31 | 81 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 2.93e-04 | 32 | 81 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 6.80e-04 | 98 | 81 | 4 | GO:0051213 | |
| GeneOntologyMolecularFunction | demethylase activity | 7.55e-04 | 44 | 81 | 3 | GO:0032451 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 1.16e-03 | 51 | 81 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 1.43e-03 | 14 | 81 | 2 | GO:0032454 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.40e-03 | 229 | 81 | 5 | GO:0140993 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | COL4A2 SLIT2 KDM5B CAD FBN1 DLL4 LRP1 KCP KMT2A DSG4 IL17RD NOS1 TNXB LRP8 SORL1 | 8.07e-07 | 850 | 80 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | response to growth factor | COL4A2 SLIT2 KDM5B CAD FBN1 DLL4 LRP1 KCP KMT2A DSG4 IL17RD NOS1 TNXB LRP8 SORL1 | 1.30e-06 | 883 | 80 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | negative regulation of Notch signaling pathway | 3.59e-05 | 48 | 80 | 4 | GO:0045746 | |
| GeneOntologyBiologicalProcess | heterochromatin formation | 4.12e-05 | 163 | 80 | 6 | GO:0031507 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 8.16e-05 | 114 | 80 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | SLIT2 SIRT2 FBN1 CDK12 LRP4 DLK1 IL17RD ZNF418 BBS12 NOTCH3 NOTCH4 SORL1 | 1.33e-04 | 875 | 80 | 12 | GO:0045596 |
| GeneOntologyBiologicalProcess | negative regulation of gene expression, epigenetic | 1.38e-04 | 203 | 80 | 6 | GO:0045814 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.48e-04 | 625 | 80 | 10 | GO:0051960 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell differentiation | 1.58e-04 | 70 | 80 | 4 | GO:0045599 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.67e-04 | 210 | 80 | 6 | GO:0007219 | |
| GeneOntologyBiologicalProcess | negative regulation of heterochromatin formation | 2.21e-04 | 6 | 80 | 2 | GO:0031452 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 SLIT2 FBN1 VWF MEGF6 LAMA2 TECTA PLOD1 SSPOP AGRN TNXB FBN3 LGALS3BP | 1.34e-06 | 656 | 81 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 SLIT2 FBN1 VWF MEGF6 LAMA2 TECTA PLOD1 SSPOP AGRN TNXB FBN3 LGALS3BP | 1.39e-06 | 658 | 81 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 SLIT2 FBN1 VWF MEGF6 LAMA2 PLOD1 SSPOP AGRN TNXB LGALS3BP | 6.12e-06 | 530 | 81 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | cell surface | SLIT2 ITGBL1 VWF ENPP3 LRP1 LRP4 ASTN1 SCART1 DLK1 TNFRSF10C AGRN NOTCH3 NOTCH4 LRP8 SORL1 | 2.08e-05 | 1111 | 81 | 15 | GO:0009986 |
| GeneOntologyCellularComponent | cell body | PCSK5 SLIT2 SIRT2 CAD KCNC3 P2RX6 LRP1 SYN1 LRP4 ASTN1 SYNDIG1 LRP8 SORL1 | 5.52e-05 | 929 | 81 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | PCSK5 SLIT2 SIRT2 CAD KCNC3 P2RX6 LRP1 LAMA2 SYN1 LRP4 ASTN1 SYNDIG1 NOS1 LRP8 SORL1 | 6.57e-05 | 1228 | 81 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | neuronal cell body | PCSK5 SLIT2 SIRT2 CAD KCNC3 P2RX6 LRP1 LRP4 ASTN1 LRP8 SORL1 | 3.65e-04 | 835 | 81 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | dendrite | PCSK5 SLIT2 KCNC3 P2RX6 LRP1 LAMA2 SYN1 LRP4 SYNDIG1 NOS1 LRP8 | 4.59e-04 | 858 | 81 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | PCSK5 SLIT2 KCNC3 P2RX6 LRP1 LAMA2 SYN1 LRP4 SYNDIG1 NOS1 LRP8 | 4.68e-04 | 860 | 81 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | postsynaptic specialization | 7.34e-04 | 503 | 81 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.11e-03 | 201 | 81 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | microfibril | 1.13e-03 | 13 | 81 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 1.30e-03 | 122 | 81 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.56e-03 | 59 | 81 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.83e-03 | 451 | 81 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | Golgi membrane | 1.87e-03 | 721 | 81 | 9 | GO:0000139 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.94e-03 | 17 | 81 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | dendritic spine | 2.50e-03 | 242 | 81 | 5 | GO:0043197 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.51e-03 | 477 | 81 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | neuron spine | 2.73e-03 | 247 | 81 | 5 | GO:0044309 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.25e-03 | 157 | 81 | 4 | GO:0098839 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 3.99e-03 | 519 | 81 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 4.16e-03 | 523 | 81 | 7 | GO:0098984 | |
| Domain | EGF | PCSK5 SLIT2 ITGBL1 FBN1 MEGF6 DLL4 LRP1 LAMA2 LRP4 CRELD2 ASTN1 DLK1 TECTA LRP1B AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 SORL1 | 1.08e-22 | 235 | 77 | 21 | SM00181 |
| Domain | EGF-like_dom | PCSK5 SLIT2 ITGBL1 FBN1 MEGF6 DLL4 LRP1 LAMA2 LRP4 CRELD2 ASTN1 DLK1 TECTA LRP1B AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 SORL1 | 3.69e-22 | 249 | 77 | 21 | IPR000742 |
| Domain | EGF_2 | SLIT2 ITGBL1 FBN1 MEGF6 DLL4 LRP1 LAMA2 LRP4 CRELD2 ASTN1 DLK1 LRP1B SSPOP AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 SORL1 | 3.80e-20 | 265 | 77 | 20 | PS01186 |
| Domain | EGF_1 | SLIT2 ITGBL1 FBN1 MEGF6 DLL4 LRP1 LAMA2 LRP4 CRELD2 ASTN1 DLK1 LRP1B SSPOP AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 | 4.74e-19 | 255 | 77 | 19 | PS00022 |
| Domain | EGF_3 | SLIT2 FBN1 MEGF6 DLL4 LRP1 LRP4 CRELD2 ASTN1 DLK1 LRP1B SSPOP AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 SORL1 | 2.75e-18 | 235 | 77 | 18 | PS50026 |
| Domain | EGF-like_CS | SLIT2 FBN1 MEGF6 DLL4 LRP1 LAMA2 LRP4 CRELD2 ASTN1 DLK1 LRP1B AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 SORL1 | 1.80e-17 | 261 | 77 | 18 | IPR013032 |
| Domain | EGF_CA | SLIT2 FBN1 MEGF6 DLL4 LRP1 LRP4 CRELD2 DLK1 LRP1B AGRN FBN3 NOTCH3 NOTCH4 LRP8 | 7.12e-17 | 122 | 77 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | SLIT2 FBN1 MEGF6 DLL4 LRP1 LRP4 CRELD2 DLK1 LRP1B AGRN FBN3 NOTCH3 NOTCH4 LRP8 | 8.99e-17 | 124 | 77 | 14 | IPR001881 |
| Domain | EGF | SLIT2 MEGF6 DLL4 LRP1 LRP4 DLK1 TECTA LRP1B AGRN TNXB FBN3 NOTCH3 NOTCH4 LRP8 | 1.13e-16 | 126 | 77 | 14 | PF00008 |
| Domain | ASX_HYDROXYL | SLIT2 FBN1 MEGF6 DLL4 LRP1 LRP4 CRELD2 DLK1 LRP1B FBN3 NOTCH3 NOTCH4 LRP8 | 1.84e-16 | 100 | 77 | 13 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | SLIT2 FBN1 MEGF6 DLL4 LRP1 LRP4 CRELD2 DLK1 LRP1B FBN3 NOTCH3 NOTCH4 LRP8 | 4.04e-16 | 106 | 77 | 13 | IPR000152 |
| Domain | Growth_fac_rcpt_ | PCSK5 FBN1 MEGF6 DLL4 LRP1 LRP4 CRELD2 LRP1B TNXB FBN3 NOTCH3 NOTCH4 LRP8 | 6.73e-14 | 156 | 77 | 13 | IPR009030 |
| Domain | EGF_Ca-bd_CS | SLIT2 FBN1 MEGF6 LRP1 LRP4 CRELD2 LRP1B FBN3 NOTCH3 NOTCH4 LRP8 | 2.09e-13 | 97 | 77 | 11 | IPR018097 |
| Domain | EGF_CA | SLIT2 FBN1 MEGF6 LRP1 LRP4 CRELD2 LRP1B FBN3 NOTCH3 NOTCH4 LRP8 | 2.63e-13 | 99 | 77 | 11 | PS01187 |
| Domain | EGF_CA | 2.13e-12 | 86 | 77 | 10 | PF07645 | |
| Domain | LDLR_class-A_CS | 2.56e-10 | 40 | 77 | 7 | IPR023415 | |
| Domain | Ldl_recept_a | 6.13e-10 | 45 | 77 | 7 | PF00057 | |
| Domain | - | 7.21e-10 | 46 | 77 | 7 | 4.10.400.10 | |
| Domain | LDLRA_1 | 9.85e-10 | 48 | 77 | 7 | PS01209 | |
| Domain | LDLRA_2 | 1.15e-09 | 49 | 77 | 7 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.15e-09 | 49 | 77 | 7 | IPR002172 | |
| Domain | LDLa | 1.15e-09 | 49 | 77 | 7 | SM00192 | |
| Domain | Ldl_recept_b | 2.03e-09 | 14 | 77 | 5 | PF00058 | |
| Domain | LDLRB | 2.03e-09 | 14 | 77 | 5 | PS51120 | |
| Domain | LY | 3.04e-09 | 15 | 77 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.04e-09 | 15 | 77 | 5 | IPR000033 | |
| Domain | EGF_extracell | 4.97e-09 | 60 | 77 | 7 | IPR013111 | |
| Domain | EGF_2 | 4.97e-09 | 60 | 77 | 7 | PF07974 | |
| Domain | cEGF | 6.42e-08 | 26 | 77 | 5 | IPR026823 | |
| Domain | cEGF | 6.42e-08 | 26 | 77 | 5 | PF12662 | |
| Domain | hEGF | 9.53e-08 | 28 | 77 | 5 | PF12661 | |
| Domain | Unchr_dom_Cys-rich | 1.86e-07 | 13 | 77 | 4 | IPR014853 | |
| Domain | C8 | 1.86e-07 | 13 | 77 | 4 | SM00832 | |
| Domain | TIL_dom | 2.59e-07 | 14 | 77 | 4 | IPR002919 | |
| Domain | VWD | 4.68e-07 | 16 | 77 | 4 | SM00216 | |
| Domain | VWF_type-D | 4.68e-07 | 16 | 77 | 4 | IPR001846 | |
| Domain | VWFD | 4.68e-07 | 16 | 77 | 4 | PS51233 | |
| Domain | VWD | 4.68e-07 | 16 | 77 | 4 | PF00094 | |
| Domain | - | 5.39e-07 | 39 | 77 | 5 | 2.120.10.30 | |
| Domain | VWC_out | 9.87e-07 | 19 | 77 | 4 | SM00215 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.25e-06 | 46 | 77 | 5 | IPR011042 | |
| Domain | Laminin_G_1 | 1.09e-05 | 11 | 77 | 3 | PF00054 | |
| Domain | TIL | 1.44e-05 | 12 | 77 | 3 | PF01826 | |
| Domain | C8 | 1.44e-05 | 12 | 77 | 3 | PF08742 | |
| Domain | DUF5050 | 1.68e-05 | 2 | 77 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.68e-05 | 2 | 77 | 2 | PF16472 | |
| Domain | VWC | 1.77e-05 | 38 | 77 | 4 | SM00214 | |
| Domain | VWFC_2 | 1.77e-05 | 38 | 77 | 4 | PS50184 | |
| Domain | Laminin_EGF | 1.77e-05 | 38 | 77 | 4 | IPR002049 | |
| Domain | VWF_dom | 2.65e-05 | 42 | 77 | 4 | IPR001007 | |
| Domain | FBN | 5.02e-05 | 3 | 77 | 2 | IPR011398 | |
| Domain | CTCK_1 | 5.26e-05 | 18 | 77 | 3 | PS01185 | |
| Domain | Notch | 1.00e-04 | 4 | 77 | 2 | IPR008297 | |
| Domain | NODP | 1.00e-04 | 4 | 77 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.00e-04 | 4 | 77 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.00e-04 | 4 | 77 | 2 | IPR010660 | |
| Domain | NOD | 1.00e-04 | 4 | 77 | 2 | PF06816 | |
| Domain | NOD | 1.00e-04 | 4 | 77 | 2 | SM01338 | |
| Domain | NODP | 1.00e-04 | 4 | 77 | 2 | SM01339 | |
| Domain | JmjC | 1.28e-04 | 24 | 77 | 3 | PF02373 | |
| Domain | Cys_knot_C | 1.45e-04 | 25 | 77 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.45e-04 | 25 | 77 | 3 | PS01225 | |
| Domain | LNR | 1.66e-04 | 5 | 77 | 2 | PS50258 | |
| Domain | - | 2.34e-04 | 73 | 77 | 4 | 2.60.120.260 | |
| Domain | PHD | 2.60e-04 | 75 | 77 | 4 | PF00628 | |
| Domain | JMJC | 3.07e-04 | 32 | 77 | 3 | PS51184 | |
| Domain | JmjC_dom | 3.07e-04 | 32 | 77 | 3 | IPR003347 | |
| Domain | Znf_PHD-finger | 3.17e-04 | 79 | 77 | 4 | IPR019787 | |
| Domain | JmjC | 3.36e-04 | 33 | 77 | 3 | SM00558 | |
| Domain | TB | 3.48e-04 | 7 | 77 | 2 | PF00683 | |
| Domain | Notch_dom | 3.48e-04 | 7 | 77 | 2 | IPR000800 | |
| Domain | Notch | 3.48e-04 | 7 | 77 | 2 | PF00066 | |
| Domain | NL | 3.48e-04 | 7 | 77 | 2 | SM00004 | |
| Domain | Laminin_EGF | 4.01e-04 | 35 | 77 | 3 | PF00053 | |
| Domain | EGF_Lam | 4.01e-04 | 35 | 77 | 3 | SM00180 | |
| Domain | VWFC_1 | 4.36e-04 | 36 | 77 | 3 | PS01208 | |
| Domain | - | 4.62e-04 | 8 | 77 | 2 | 3.90.290.10 | |
| Domain | PHD | 5.00e-04 | 89 | 77 | 4 | SM00249 | |
| Domain | LAM_G_DOMAIN | 5.12e-04 | 38 | 77 | 3 | PS50025 | |
| Domain | Znf_PHD | 5.44e-04 | 91 | 77 | 4 | IPR001965 | |
| Domain | TB | 5.93e-04 | 9 | 77 | 2 | PS51364 | |
| Domain | TB_dom | 5.93e-04 | 9 | 77 | 2 | IPR017878 | |
| Domain | Galactose-bd-like | 6.15e-04 | 94 | 77 | 4 | IPR008979 | |
| Domain | ZF_PHD_2 | 6.40e-04 | 95 | 77 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 6.66e-04 | 96 | 77 | 4 | PS01359 | |
| Domain | LamG | 7.90e-04 | 44 | 77 | 3 | SM00282 | |
| Domain | Fol_N | 9.01e-04 | 11 | 77 | 2 | IPR003645 | |
| Domain | FOLN | 9.01e-04 | 11 | 77 | 2 | SM00274 | |
| Domain | - | 1.27e-03 | 13 | 77 | 2 | 3.40.50.20 | |
| Domain | PreATP-grasp_dom | 1.48e-03 | 14 | 77 | 2 | IPR016185 | |
| Domain | PLipase_C_Pinositol-sp_Y | 1.70e-03 | 15 | 77 | 2 | IPR001711 | |
| Domain | EF-hand_like | 1.70e-03 | 15 | 77 | 2 | PF09279 | |
| Domain | PIPLC_Y_DOMAIN | 1.70e-03 | 15 | 77 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 1.70e-03 | 15 | 77 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 1.70e-03 | 15 | 77 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 1.70e-03 | 15 | 77 | 2 | PF00387 | |
| Domain | PLCYc | 1.70e-03 | 15 | 77 | 2 | SM00149 | |
| Domain | - | 1.70e-03 | 15 | 77 | 2 | 3.30.1490.20 | |
| Domain | Laminin_G | 1.77e-03 | 58 | 77 | 3 | IPR001791 | |
| Domain | EMI | 2.19e-03 | 17 | 77 | 2 | PS51041 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.52e-06 | 27 | 62 | 4 | M39545 | |
| Pathway | PID_NOTCH_PATHWAY | 5.82e-06 | 59 | 62 | 5 | M17 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.99e-06 | 300 | 62 | 9 | M610 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.03e-05 | 76 | 62 | 5 | M27219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.25e-05 | 13 | 62 | 3 | M47423 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.30e-05 | 84 | 62 | 5 | M7098 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.42e-05 | 45 | 62 | 4 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 5.71e-05 | 48 | 62 | 4 | M27642 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.32e-04 | 258 | 62 | 7 | MM14572 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.89e-04 | 5 | 62 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.89e-04 | 5 | 62 | 2 | MM14733 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 2.50e-04 | 381 | 62 | 8 | M48063 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 2.73e-04 | 29 | 62 | 3 | MM14934 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.82e-04 | 6 | 62 | 2 | M27068 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.94e-04 | 7 | 62 | 2 | MM14734 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.26e-04 | 85 | 62 | 4 | M16441 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 5.66e-04 | 37 | 62 | 3 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.61e-04 | 39 | 62 | 3 | MM14604 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.99e-04 | 161 | 62 | 5 | M39770 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 7.10e-04 | 92 | 62 | 4 | MM14881 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 9.70e-04 | 100 | 62 | 4 | M27158 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.01e-03 | 45 | 62 | 3 | M39571 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.02e-03 | 11 | 62 | 2 | M27882 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.02e-03 | 11 | 62 | 2 | M47865 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.07e-03 | 46 | 62 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.14e-03 | 47 | 62 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.22e-03 | 12 | 62 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.22e-03 | 12 | 62 | 2 | M47533 | |
| Pathway | REACTOME_HDMS_DEMETHYLATE_HISTONES | 1.37e-03 | 50 | 62 | 3 | M27232 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.44e-03 | 13 | 62 | 2 | M47534 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 1.76e-03 | 198 | 62 | 5 | M18311 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.93e-03 | 15 | 62 | 2 | MM14922 | |
| Pathway | WP_GPR40_PATHWAY | 1.93e-03 | 15 | 62 | 2 | M39526 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.20e-03 | 16 | 62 | 2 | M47424 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.21e-03 | 59 | 62 | 3 | M27218 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.43e-03 | 61 | 62 | 3 | M39540 | |
| Pubmed | 1.26e-11 | 175 | 82 | 10 | 28071719 | ||
| Pubmed | 3.58e-09 | 9 | 82 | 4 | 23986861 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.68e-09 | 248 | 82 | 9 | 24006456 | |
| Pubmed | 1.33e-08 | 118 | 82 | 7 | 21078624 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL4A2 FBN1 SCAP LRP10 MBOAT7 LRP1 LRP4 CRELD2 PLOD1 LRP1B AGRN NOTCH3 LGALS3BP DMXL1 LRP8 SORL1 | 1.81e-08 | 1201 | 82 | 16 | 35696571 |
| Pubmed | 5.81e-08 | 146 | 82 | 7 | 27068509 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 6.67e-08 | 17 | 82 | 4 | 15821257 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.19e-07 | 97 | 82 | 6 | 27559042 | |
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 19047013 | ||
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 1.26e-07 | 5 | 82 | 3 | 21726900 | |
| Pubmed | 1.26e-07 | 5 | 82 | 3 | 23675950 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.67e-07 | 21 | 82 | 4 | 21337463 | |
| Pubmed | 2.51e-07 | 6 | 82 | 3 | 17822320 | ||
| Pubmed | 4.39e-07 | 7 | 82 | 3 | 25368159 | ||
| Pubmed | 4.40e-07 | 64 | 82 | 5 | 22261194 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 8.19e-07 | 560 | 82 | 10 | 21653829 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 8.41e-07 | 135 | 82 | 6 | 28675934 | |
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 12122015 | ||
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 16245338 | ||
| Pubmed | 1.05e-06 | 9 | 82 | 3 | 20005821 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.50e-06 | 10 | 82 | 3 | 23665443 | |
| Pubmed | 2.06e-06 | 11 | 82 | 3 | 24639464 | ||
| Pubmed | 2.61e-06 | 164 | 82 | 6 | 32409323 | ||
| Pubmed | 2.74e-06 | 12 | 82 | 3 | 15465494 | ||
| Pubmed | 2.90e-06 | 167 | 82 | 6 | 22159717 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 3.55e-06 | 13 | 82 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 3.55e-06 | 13 | 82 | 3 | 20558824 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 4.27e-06 | 101 | 82 | 5 | 20551380 | |
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 28192800 | ||
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 14757642 | ||
| Pubmed | Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1. | 5.16e-06 | 48 | 82 | 4 | 28924218 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25687759 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 5.49e-06 | 2 | 82 | 2 | 15963947 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25169943 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 5.49e-06 | 2 | 82 | 2 | 33665264 | |
| Pubmed | Loss of apolipoprotein E receptor LR11 in Alzheimer disease. | 5.49e-06 | 2 | 82 | 2 | 15313836 | |
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 5.49e-06 | 2 | 82 | 2 | 12871934 | |
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 5.49e-06 | 2 | 82 | 2 | 17696940 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20005200 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22534467 | ||
| Pubmed | Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses. | 5.49e-06 | 2 | 82 | 2 | 22854782 | |
| Pubmed | Association study between the TNXB locus and schizophrenia in a Japanese population. | 5.49e-06 | 2 | 82 | 2 | 17192952 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16103356 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 5.49e-06 | 2 | 82 | 2 | 24484584 | |
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 5.49e-06 | 2 | 82 | 2 | 11777956 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12814948 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 21045140 | ||
| Pubmed | Enhanced Notch3 signaling contributes to pulmonary emphysema in a Murine Model of Marfan syndrome. | 5.49e-06 | 2 | 82 | 2 | 32616814 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33913039 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 15221638 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25658374 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19208840 | ||
| Pubmed | Expressions and Prognostic Values of Notch3 and DLL4 in Human Breast Cancer. | 5.49e-06 | 2 | 82 | 2 | 36740988 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24943269 | ||
| Pubmed | 5.61e-06 | 49 | 82 | 4 | 34368113 | ||
| Pubmed | 5.63e-06 | 15 | 82 | 3 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 6.92e-06 | 16 | 82 | 3 | 12617809 | |
| Pubmed | 6.92e-06 | 16 | 82 | 3 | 17273555 | ||
| Pubmed | 8.39e-06 | 17 | 82 | 3 | 18694942 | ||
| Pubmed | 8.39e-06 | 17 | 82 | 3 | 39315665 | ||
| Pubmed | 1.00e-05 | 18 | 82 | 3 | 18093989 | ||
| Pubmed | 1.00e-05 | 18 | 82 | 3 | 15689374 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 SIRT2 SCAP WIZ MEGF6 CDK12 TMEM94 LRP4 LRRK1 HERC2 IL17RD AGRN | 1.07e-05 | 1105 | 82 | 12 | 35748872 |
| Pubmed | 1.18e-05 | 59 | 82 | 4 | 21421844 | ||
| Pubmed | 1.19e-05 | 19 | 82 | 3 | 35340430 | ||
| Pubmed | 1.19e-05 | 19 | 82 | 3 | 16518823 | ||
| Pubmed | 1.45e-05 | 613 | 82 | 9 | 22268729 | ||
| Pubmed | 1.63e-05 | 21 | 82 | 3 | 28656980 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 1.63e-05 | 21 | 82 | 3 | 27626377 | |
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 1.64e-05 | 3 | 82 | 2 | 25846406 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24244707 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 32730638 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21969364 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 11992244 | ||
| Pubmed | Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. | 1.64e-05 | 3 | 82 | 2 | 15645445 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 28799085 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 26472724 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21094132 | ||
| Pubmed | Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo. | 1.64e-05 | 3 | 82 | 2 | 24251389 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20472562 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 37971882 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 25728415 | ||
| Pubmed | Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. | 1.64e-05 | 3 | 82 | 2 | 22066479 | |
| Pubmed | Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. | 1.64e-05 | 3 | 82 | 2 | 27322543 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 16951162 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 12807892 | ||
| Pubmed | 2.16e-05 | 23 | 82 | 3 | 14701881 | ||
| Pubmed | 2.16e-05 | 23 | 82 | 3 | 36239412 | ||
| Pubmed | 2.47e-05 | 71 | 82 | 4 | 33541421 | ||
| Pubmed | 3.16e-05 | 26 | 82 | 3 | 25446530 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 3.16e-05 | 26 | 82 | 3 | 19369401 | |
| Pubmed | 3.20e-05 | 153 | 82 | 5 | 25037231 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21527992 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21041529 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20093106 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 24145721 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.28e-05 | 4 | 82 | 2 | 19404845 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 28669409 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 3.28e-05 | 4 | 82 | 2 | 25034023 | |
| Interaction | ZFP41 interactions | 5.49e-11 | 57 | 79 | 8 | int:ZFP41 | |
| Interaction | NTN5 interactions | 3.26e-08 | 24 | 79 | 5 | int:NTN5 | |
| Interaction | IGFL3 interactions | 4.86e-07 | 75 | 79 | 6 | int:IGFL3 | |
| Interaction | ZNF224 interactions | 1.01e-06 | 20 | 79 | 4 | int:ZNF224 | |
| Interaction | FEZF1 interactions | 4.17e-06 | 28 | 79 | 4 | int:FEZF1 | |
| Interaction | CACNA1A interactions | 8.83e-06 | 123 | 79 | 6 | int:CACNA1A | |
| Interaction | HOXA1 interactions | 1.05e-05 | 356 | 79 | 9 | int:HOXA1 | |
| Interaction | TMEM94 interactions | 1.17e-05 | 36 | 79 | 4 | int:TMEM94 | |
| Interaction | ZNF563 interactions | 1.24e-05 | 12 | 79 | 3 | int:ZNF563 | |
| Interaction | IGSF5 interactions | 2.05e-05 | 14 | 79 | 3 | int:IGSF5 | |
| Interaction | ZNF408 interactions | 2.26e-05 | 145 | 79 | 6 | int:ZNF408 | |
| Interaction | DEFB123 interactions | 3.13e-05 | 16 | 79 | 3 | int:DEFB123 | |
| Interaction | FBXO2 interactions | 3.26e-05 | 411 | 79 | 9 | int:FBXO2 | |
| Interaction | FBXL5 interactions | 3.43e-05 | 47 | 79 | 4 | int:FBXL5 | |
| Interaction | MFAP5 interactions | 5.13e-05 | 52 | 79 | 4 | int:MFAP5 | |
| Interaction | ATXN7 interactions | 6.92e-05 | 109 | 79 | 5 | int:ATXN7 | |
| Interaction | NOTCH4 interactions | 7.33e-05 | 21 | 79 | 3 | int:NOTCH4 | |
| Interaction | ANKRD36B interactions | 9.03e-05 | 60 | 79 | 4 | int:ANKRD36B | |
| Interaction | TMEM121B interactions | 9.06e-05 | 4 | 79 | 2 | int:TMEM121B | |
| Interaction | FBXO6 interactions | COL4A2 CAD LRP10 ENPP3 LRP1 TUT1 PLOD1 AGRN LGALS3BP SORL1 COPS7A | 1.07e-04 | 717 | 79 | 11 | int:FBXO6 |
| Interaction | COL5A1 interactions | 1.23e-04 | 65 | 79 | 4 | int:COL5A1 | |
| Interaction | HSP90B1 interactions | 2.21e-04 | 650 | 79 | 10 | int:HSP90B1 | |
| Interaction | DLL4 interactions | 2.25e-04 | 6 | 79 | 2 | int:DLL4 | |
| Interaction | CPLX3 interactions | 2.41e-04 | 31 | 79 | 3 | int:CPLX3 | |
| GeneFamily | Low density lipoprotein receptors | 2.73e-10 | 13 | 55 | 5 | 634 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 5.15e-05 | 24 | 55 | 3 | 485 | |
| GeneFamily | PHD finger proteins | 1.61e-04 | 90 | 55 | 4 | 88 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 1.50e-03 | 19 | 55 | 2 | 832 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.72e-11 | 196 | 82 | 11 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 SLIT2 FBN1 VWF LAMA2 KCP CRELD2 TECTA SSPOP AGRN TNXB FBN3 | 6.04e-11 | 275 | 82 | 12 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.52e-10 | 191 | 82 | 10 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 SLIT2 FBN1 VWF LAMA2 KCP CRELD2 TECTA SSPOP AGRN TNXB | 8.29e-10 | 270 | 82 | 11 | MM17057 |
| Coexpression | NABA_MATRISOME | COL4A2 PCSK5 SLIT2 FBN1 VWF MEGF6 LAMA2 KCP CRELD2 TECTA PLOD1 SSPOP AGRN TNXB FBN3 | 6.00e-07 | 1026 | 82 | 15 | M5889 |
| Coexpression | LEE_BMP2_TARGETS_UP | VWF LRP10 ENPP3 LRP1 LAMA2 KDM7A LRRK1 IL17RD PLOD1 AGRN TNXB RECK NOTCH3 | 8.74e-07 | 780 | 82 | 13 | M2324 |
| Coexpression | LEE_BMP2_TARGETS_UP | VWF LRP10 ENPP3 LRP1 LAMA2 KDM7A LRRK1 IL17RD PLOD1 AGRN TNXB RECK NOTCH3 | 1.24e-06 | 805 | 82 | 13 | MM1067 |
| Coexpression | NABA_MATRISOME | COL4A2 PCSK5 SLIT2 FBN1 VWF MEGF6 LAMA2 KCP CRELD2 TECTA PLOD1 SSPOP AGRN TNXB | 2.72e-06 | 1008 | 82 | 14 | MM17056 |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE | 4.11e-06 | 76 | 82 | 5 | M1685 | |
| Coexpression | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE | 7.56e-06 | 86 | 82 | 5 | MM1209 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.60e-05 | 16 | 82 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.60e-05 | 16 | 82 | 3 | M2207 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.80e-05 | 261 | 82 | 7 | M1834 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.90e-05 | 365 | 82 | 8 | M39018 | |
| Coexpression | HEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS | 2.76e-05 | 19 | 82 | 3 | MM420 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 3.96e-05 | 200 | 82 | 6 | M5068 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.96e-05 | 200 | 82 | 6 | M5930 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 4.66e-05 | 303 | 82 | 7 | M39040 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 9.22e-05 | 233 | 82 | 6 | M13273 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | COL4A2 PCSK5 KDM5B WDHD1 DLL4 TMEM94 KCP LRP4 DLK1 NOTCH3 LRP8 | 1.02e-04 | 891 | 82 | 11 | M45033 |
| Coexpression | PEREZ_TP63_TARGETS | 1.28e-04 | 356 | 82 | 7 | M10761 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.62e-04 | 163 | 82 | 5 | M12112 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 1.86e-04 | 795 | 82 | 10 | M39050 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.31e-04 | 276 | 82 | 6 | M3063 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_2_DN | 2.45e-04 | 279 | 82 | 6 | M16867 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 2.68e-04 | 40 | 82 | 3 | M5887 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.51e-05 | 437 | 79 | 9 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.04e-05 | 445 | 79 | 9 | GSM777043_500 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.10e-09 | 187 | 82 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.92e-09 | 195 | 82 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-08 | 160 | 82 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-08 | 160 | 82 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-08 | 168 | 82 | 7 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-08 | 171 | 82 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.15e-08 | 172 | 82 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-08 | 176 | 82 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-08 | 176 | 82 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.39e-08 | 186 | 82 | 7 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-08 | 192 | 82 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-08 | 192 | 82 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.70e-08 | 192 | 82 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-08 | 192 | 82 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-08 | 193 | 82 | 7 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.94e-08 | 193 | 82 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.19e-08 | 194 | 82 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.45e-08 | 195 | 82 | 7 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.45e-08 | 195 | 82 | 7 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-08 | 196 | 82 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-08 | 196 | 82 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-08 | 196 | 82 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-08 | 196 | 82 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.56e-08 | 199 | 82 | 7 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 8.85e-08 | 200 | 82 | 7 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.85e-08 | 200 | 82 | 7 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.85e-08 | 200 | 82 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.75e-07 | 163 | 82 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-07 | 169 | 82 | 6 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-07 | 169 | 82 | 6 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-07 | 169 | 82 | 6 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.71e-07 | 175 | 82 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.00e-07 | 176 | 82 | 6 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-06 | 180 | 82 | 6 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 181 | 82 | 6 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 181 | 82 | 6 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-06 | 181 | 82 | 6 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-06 | 182 | 82 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-06 | 184 | 82 | 6 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 184 | 82 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 184 | 82 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 185 | 82 | 6 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-06 | 185 | 82 | 6 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-06 | 185 | 82 | 6 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 186 | 82 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-06 | 186 | 82 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 187 | 82 | 6 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 188 | 82 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.32e-06 | 188 | 82 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-06 | 189 | 82 | 6 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 189 | 82 | 6 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-06 | 189 | 82 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-06 | 189 | 82 | 6 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.36e-06 | 189 | 82 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 190 | 82 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 190 | 82 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-06 | 191 | 82 | 6 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-06 | 191 | 82 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 191 | 82 | 6 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.45e-06 | 191 | 82 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-06 | 191 | 82 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 192 | 82 | 6 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 192 | 82 | 6 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-06 | 192 | 82 | 6 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-06 | 192 | 82 | 6 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-06 | 193 | 82 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-06 | 193 | 82 | 6 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.59e-06 | 194 | 82 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-06 | 195 | 82 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-06 | 195 | 82 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 195 | 82 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 195 | 82 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 195 | 82 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-06 | 195 | 82 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 195 | 82 | 6 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 196 | 82 | 6 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-06 | 196 | 82 | 6 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.68e-06 | 196 | 82 | 6 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-06 | 197 | 82 | 6 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-06 | 197 | 82 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.73e-06 | 197 | 82 | 6 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.73e-06 | 197 | 82 | 6 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-06 | 197 | 82 | 6 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.73e-06 | 197 | 82 | 6 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-06 | 197 | 82 | 6 | 6b6440f1baad5680cf9e13ca3ab72a2c65523d59 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.73e-06 | 197 | 82 | 6 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.79e-06 | 198 | 82 | 6 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.79e-06 | 198 | 82 | 6 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-06 | 199 | 82 | 6 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.84e-06 | 199 | 82 | 6 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| Computational | ECM and collagens. | 1.23e-04 | 225 | 54 | 7 | MODULE_47 | |
| Drug | monatepil | 5.24e-08 | 29 | 80 | 5 | CID000060810 | |
| Drug | pitavastatin | 1.54e-07 | 114 | 80 | 7 | CID005282451 | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.64e-07 | 197 | 80 | 8 | 3415_DN | |
| Drug | 25-hydroxycholesterol | 1.53e-06 | 160 | 80 | 7 | CID000065094 | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.49e-06 | 199 | 80 | 7 | 2243_DN | |
| Drug | ezetimibe | 1.33e-05 | 147 | 80 | 6 | CID000150311 | |
| Drug | reactive blue 2 | 1.39e-05 | 87 | 80 | 5 | CID000656725 | |
| Drug | Epi Lovastatin | 2.65e-05 | 341 | 80 | 8 | CID000003962 | |
| Drug | AC1Q5S71 | 3.02e-05 | 170 | 80 | 6 | CID000000501 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 4.99e-05 | 186 | 80 | 6 | 4463_UP | |
| Drug | Calpain inhibitor I | 5.83e-05 | 280 | 80 | 7 | CID000004332 | |
| Drug | hexaconazole | 6.30e-05 | 119 | 80 | 5 | ctd:C409722 | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | 6.31e-05 | 194 | 80 | 6 | 1437_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 3408_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 6695_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.49e-05 | 195 | 80 | 6 | 7225_DN | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.67e-05 | 196 | 80 | 6 | 2755_DN | |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; HL60; HG-U133A | 6.67e-05 | 196 | 80 | 6 | 1770_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HG-U133A | 6.86e-05 | 197 | 80 | 6 | 1941_DN | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 7.06e-05 | 198 | 80 | 6 | 7282_UP | |
| Drug | epicholesterol | 7.64e-05 | 636 | 80 | 10 | CID000000304 | |
| Drug | Lopac-P-178 | 9.15e-05 | 67 | 80 | 4 | CID005478935 | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.01e-05 | 3 | 77 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | hemangioblastoma (is_marker_for) | 4.02e-05 | 4 | 77 | 2 | DOID:5241 (is_marker_for) | |
| Disease | cortical surface area measurement | SLIT2 FBN1 MEGF6 ENPP3 CHAF1A LAMA2 IL17RD GK5 TNXB FBN3 LRP8 PLCE1 COPS7A | 4.19e-05 | 1345 | 77 | 13 | EFO_0010736 |
| Disease | spontaneous coronary artery dissection | 7.29e-05 | 31 | 77 | 3 | EFO_0010820 | |
| Disease | Hypotrichosis simplex | 1.40e-04 | 7 | 77 | 2 | C1854310 | |
| Disease | cortical thickness | COL4A2 SLIT2 FBN1 CHAF1A LRP1 LAMA2 LRP4 KMT2A PLCH1 LRP8 PLCE1 | 1.43e-04 | 1113 | 77 | 11 | EFO_0004840 |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.86e-04 | 8 | 77 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 1.86e-04 | 8 | 77 | 2 | DOID:4783 (biomarker_via_orthology) | |
| Disease | hemangiopericytoma (is_marker_for) | 2.39e-04 | 9 | 77 | 2 | DOID:264 (is_marker_for) | |
| Disease | aortic aneurysm | 2.98e-04 | 10 | 77 | 2 | EFO_0001666 | |
| Disease | ubiquitin-conjugating enzyme E2 G2 measurement | 2.98e-04 | 10 | 77 | 2 | EFO_0022035 | |
| Disease | Small cell carcinoma of lung | 3.85e-04 | 54 | 77 | 3 | C0149925 | |
| Disease | Alzheimer's disease (is_implicated_in) | 4.02e-04 | 132 | 77 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 4.36e-04 | 12 | 77 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | dementia (is_implicated_in) | 4.36e-04 | 12 | 77 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | 4.70e-04 | 1074 | 77 | 10 | C0006142 | |
| Disease | Schizophrenia | 4.83e-04 | 883 | 77 | 9 | C0036341 | |
| Disease | Migraine Disorders | 5.15e-04 | 13 | 77 | 2 | C0149931 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 5.15e-04 | 13 | 77 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | Impaired cognition | 5.99e-04 | 14 | 77 | 2 | C0338656 | |
| Disease | transient cerebral ischemia (implicated_via_orthology) | 6.35e-04 | 64 | 77 | 3 | DOID:224 (implicated_via_orthology) | |
| Disease | glaucoma | 7.18e-04 | 154 | 77 | 4 | MONDO_0005041 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 7.88e-04 | 16 | 77 | 2 | C0751885 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 7.88e-04 | 16 | 77 | 2 | EFO_0020346 | |
| Disease | depressive symptom measurement | 8.74e-04 | 426 | 77 | 6 | EFO_0007006 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 8.91e-04 | 17 | 77 | 2 | C0751883 | |
| Disease | cervical artery dissection | 8.91e-04 | 17 | 77 | 2 | EFO_1000059 | |
| Disease | colorectal cancer | 1.01e-03 | 604 | 77 | 7 | MONDO_0005575 | |
| Disease | X-11470 measurement | 1.12e-03 | 19 | 77 | 2 | EFO_0021241 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 1.12e-03 | 19 | 77 | 2 | C0751884 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.12e-03 | 19 | 77 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 1.12e-03 | 19 | 77 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | FEV/FEC ratio | 1.31e-03 | 1228 | 77 | 10 | EFO_0004713 | |
| Disease | descending aortic diameter | 1.60e-03 | 88 | 77 | 3 | EFO_0021788 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.64e-03 | 23 | 77 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | age-related macular degeneration | 1.65e-03 | 89 | 77 | 3 | EFO_0001365 | |
| Disease | Myasthenic Syndromes, Congenital | 1.79e-03 | 24 | 77 | 2 | C0751882 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.79e-03 | 24 | 77 | 2 | C0887833 | |
| Disease | systemic scleroderma (is_implicated_in) | 1.79e-03 | 24 | 77 | 2 | DOID:418 (is_implicated_in) | |
| Disease | complement C4b measurement | 1.94e-03 | 25 | 77 | 2 | EFO_0008092 | |
| Disease | Squamous cell carcinoma of esophagus | 1.99e-03 | 95 | 77 | 3 | C0279626 | |
| Disease | myeloperoxidase measurement | 2.10e-03 | 26 | 77 | 2 | EFO_0005243 | |
| Disease | migraine disorder, pulse pressure measurement | 2.10e-03 | 26 | 77 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | intraocular pressure measurement | 2.16e-03 | 509 | 77 | 6 | EFO_0004695 | |
| Disease | Hypermetropia | 2.51e-03 | 103 | 77 | 3 | HP_0000540 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AIDVWSCGCILGELF | 916 | Q9NYV4 | |
| EWCVGCEVVLSGIEE | 176 | Q9UBW8 | |
| AEWCQIFDGTDACVT | 281 | Q9UHK6 | |
| TASEWLDLFCDCLGC | 2206 | Q7Z2Y8 | |
| WYSCEEELSGLGEKC | 106 | Q6UXU4 | |
| GGIWDEDSEDGPCVC | 691 | O00468 | |
| WKGDAGECRCTEGDE | 476 | P08572 | |
| TCDEGWGGLFCDQDL | 271 | Q9NR61 | |
| IGCVWAADRDCAGDD | 686 | Q13111 | |
| GWVGDGFECHDLDEC | 1311 | Q75N90 | |
| CTDGWDGELCDRDVR | 76 | P80370 | |
| NEDCVGDGVCVTFWR | 461 | Q6ZW61 | |
| FECESTGGSCWVLEQ | 1081 | Q9Y485 | |
| SGTGDVIEDWCRCDS | 1001 | O14525 | |
| SDGWVGLGCCELAIA | 96 | O95980 | |
| DICKDWFHGSCVGVE | 56 | Q6ZMT4 | |
| LQDFCGCEVALDLWE | 381 | Q8NFM7 | |
| GCEVALDLWEDFSLC | 386 | Q8NFM7 | |
| WVCDGQPDCADGSDE | 416 | Q7Z4F1 | |
| HWICDGEDDCGDGLD | 2736 | Q9NZR2 | |
| CEGFEPCKGDWVEAE | 146 | Q9BXT6 | |
| CEGLFVADVTDFEGW | 526 | Q08380 | |
| CSSEGRGEEVVWCLD | 1741 | Q38SD2 | |
| CVCCTEDGEVYTWGD | 4261 | O95714 | |
| CSCYEGWVLEPDGES | 1246 | Q07954 | |
| GSIGCCSWIVDDLDE | 816 | Q86SJ6 | |
| ESSWVLYDGLCLEEC | 1391 | Q92824 | |
| SDAFWLEDCAQVEEG | 241 | Q8IXQ8 | |
| CDWEEVTTSGPCGEE | 1721 | Q92817 | |
| TLDCGWIVSDCTAEA | 446 | P48449 | |
| EECGWDGLDCASEVP | 1491 | Q9UM47 | |
| YVAWIAAECGCIAAG | 246 | Q96N66 | |
| REGWECVFCGDECTG | 1566 | P24043 | |
| GVSGLAAIWCCLEEG | 11 | O60774 | |
| EGDEVDWVQCDGSCN | 1496 | Q9UGL1 | |
| AWVGVSCCELAEEDF | 6 | Q3KNT7 | |
| WTFETGCTVCDEGLR | 261 | Q02809 | |
| EGDELCGQEEAFRTW | 921 | P29475 | |
| KDRGDCCWDFEDTCV | 76 | O14638 | |
| CCSVGAAWGTEECEE | 981 | P35555 | |
| VEEENCCFGTIDTWL | 186 | Q6ZS86 | |
| CDVEGCTWKFARSDE | 996 | A0A0U1RQI7 | |
| DDGFQICAESIEDAW | 3676 | Q03164 | |
| NRDCGECEVGWVLDE | 211 | Q6UXH1 | |
| ECEVGWVLDEGACVD | 216 | Q6UXH1 | |
| WVLDEGACVDVDECA | 221 | Q6UXH1 | |
| VWDAIEGVLCCSSEE | 991 | Q12770 | |
| WGDIHGDTCECDERD | 261 | O95965 | |
| ERWKCDGEEECPDGS | 101 | Q14114 | |
| WRCDGEKDCEGGADE | 146 | Q14114 | |
| ANCWVDEDCPEGEGG | 136 | O15547 | |
| GEDCEADCPEGRWGL | 766 | O75095 | |
| FWDGKEVSEEAGPCC | 911 | Q5JY77 | |
| WVDTCSEIFGGLDIC | 356 | P17600 | |
| WVCDGYRDCADGSDE | 1436 | Q92673 | |
| CKDWFHGSCVGVEEE | 26 | O75151 | |
| LCDGVWDCPDGADEG | 1511 | A2VEC9 | |
| FLGCRGLEALEGCWD | 506 | Q9BXQ6 | |
| SWGDGVAADCCETTF | 101 | Q9H7V2 | |
| EGEGRIEWCCSVCRE | 91 | Q1RMZ1 | |
| QGCRSVELDCWDGDD | 1431 | Q9P212 | |
| DGEEFEGPAGSCEWC | 911 | Q6ZWJ8 | |
| RDVAWLGECDQGCLA | 316 | Q8IXJ6 | |
| CGECGWAFADPTALE | 306 | O95785 | |
| GWGGTSCEENLDDCI | 346 | Q99466 | |
| EDDWVCCATLEGHES | 181 | O76071 | |
| ESWTTFEEICNGECG | 876 | O75443 | |
| DGCGIACAIVTWFLV | 41 | Q9NYG2 | |
| GQFWEEGCDVCTCTD | 2441 | P04275 | |
| ADVVLEACTDFWDGA | 706 | Q12767 | |
| GEGEQVEVDGWDCSF | 461 | Q9H6E5 | |
| CGSDGDVRIWEDLDD | 31 | O75717 | |
| SECEEGAGDFLWLDQ | 216 | Q6ZMY3 | |
| QDGVCICWEGYVSED | 601 | P22105 | |
| CTSWDDIQCVEEFGA | 141 | O14798 | |
| ADWCSEGECLAAINS | 616 | Q8IYQ7 | |
| CDDGWDLADAEVVCR | 811 | Q4G0T1 | |
| TCHLKEGEEDGFWCI | 971 | O94813 | |
| EGEEDGFWCICADGF | 976 | O94813 | |
| LRCEGECWLFDCGEG | 26 | Q9H777 | |
| LQEGCRCVEVDCWDG | 336 | Q4KWH8 | |
| GSSVEFDWCAVGCIQ | 946 | P27708 | |
| ISSLGCWCGSEDEEA | 41 | Q8TF45 | |
| DGAENSCTERDGWCL | 426 | Q9Y5Q8 | |
| ISSLGCWCGVEDEAA | 51 | B7Z6K7 | |
| SGSEDEDWICLAGVD | 321 | Q6ZT21 | |
| LGFWGIDETDVEACC | 171 | Q14003 | |
| EGICLLSGDDAEWDD | 1811 | O75096 |